Reach out to the fastest growing market of South East Asia
Trade Bodies - Page No. 8
ASIA PHARMA EXPO 2004 (APE2004), the first ever-international exhibition of Malaysia announced here, that is scheduled during April 21 and 23, 2004 at Mid Valley Exhibition Centre, Kuala Lumpur, Malaysia.
Asia Pharma Expo has been consistently working towards building a global pharma society. Over the years, the event has brought together a guild manufacturers, pharma publishers, R&D analysts, associations and environmentalists every time and has helped in expanding knowledge, know-how, technology and opportunities in the pharma sector.
Why Asia Pharma Expo 2004 in Malaysia?
Malaysia presents the best opportunity for expansion in to SE-Asia.
The market growth rate of the Malaysian pharmaceutical industry is 8 to 10%.
Total 254 pharma formulation units Total 254 pharma formulation units
Malaysia has become one of the first countries in the Association of Southeast Asia Nations (ASIAN) to gain the membership in Europe's Pharmaceutical Inspection Cooperation Scheme (PICS) in January 2002. The recognition has enabled Malaysian pharma companies more easily to export their products to PICS members, mainly in the European Union.
This is the first ever mega show exclusively focused on Malaysian pharma industry
Visitors expected from Pharma, Cosmetic, Alternate Medicine and Food Industry
International participation from Pharma fraternities of countries like Singapore, Indonesia, Thailand, Philippines, Sri Lanka, India, China
Show supported by the Government, Trade Associations, the Industry and Embassies
The Country presents a growing market, that's expanding limitlessly
Mr. Bhullar, ABC Exhibitions, Malaysia, the Organiser of APE2004 informed that the event is the concurrent exhibition with the 9th Southeast Asia Healthcare Show, and being supported by Government, Trade Associations, and various Embassies, that include Ministry of Health, Malaysia Malaysian External Trade Development Corporation (MATRADE), Malaysian Industrial Development Authority (MIDA), Malaysian Organisation of Pharmaceutical Industries (MOPI), National Sports Institute, British High Commission, Kuala Lumpur, The American Embassy, Austrian Embassy Office of the Commercial Counselor, Embassy of Switzerland, Kuala Lumpur and Indian Drug Manufacturers Association (IDMA) to promote trade between two countries.
For further information and exhibition stall booking, contact:
Malaysian Organisation of pharmaceutical Industries (MOPI) as started by eight manufacturers, which were local, foreign and joint venture companies.
MOPI was incorporated on 6 March 1981 as a company limited by guarantee. Raja Zainal Abidin bin Raja Haji Takchik of Raza Manufacturing SDN BHD was MOPI's first president.
MOPI's membership is restricted manufacturers with factories in Malaysia that are licensed by the drug Control Authority, Ministry of health, to manufacture pharmaceuticals.
MOPI's original membership of eight has grown to the current 34. All major pharmaceutical manufacturers in the country are members of MOPI.
Main Activities:
MOPI, in co-operation with the government and other bodies, represent the interests of the pharmaceutical industry.
Promotion and development of the industry
Foster closer co-operation among members of the Industry.
Facilitate and encourage the development, exchange and transfer of information and technology, domestically and internationally.
Promote and facilitate orderly trade in life science products.
MOPI's Strategic Role:
The MOPI membership collectively reduces about 35 percent of Malaysia's medicine requirement. In terms of product range, MOPI members have the capabilities to manufacture more than 80 percent of the product categories in the National Essential Drugs List of Malaysia.
To a large extent, MOPI's existence has been a medium and catalyst for the rapid development and capitalisation of the local pharmaceutical industry during the last decade.
It has evolved into a modern, sophisticated sector of the Malaysian economy, and it is capable of producing a wide range of products in compliance with the WHO Code of Good Manufacturing Practice and internationally accepted pharmacopoeia standards.
MOPI has also taken on the role of training personnel in the industry in the latest technologies evolving in the industry, including training in validation procedures for processes as well as equipment and also in current Good Manufacturing Practice according to the European (PIC) Code as Malaysia is expected to be a member of the PIC/S soon.
Having invested in the high-technology machineries and equipment and formalized training, MOPI members now have the capability to manufacture a wide range of products including large and small injectables, novel drug delivery systems, high technology testing and analytical equipment to met inter-nationally accepted standards of quality assurance.
Research and development is an-other key area for the MOPI membership. The focus areas are product development, formulation improvement, dosage fabrication and novel drug delivery systems which are carried out either in-house or in collaboration with University Sains Malaysia and other tertiary institutions in the country.
Federation of Malaysian Manufacturers:
MOPI is an association member of the Federation of Malaysian Manufacturers (FMM) and in that capacity serves as the pharmaceutical industry's liaison with other industries.
ASEAN Pharmaceutical Club:
MOPI represents the Malaysian Pharmaceutical industry in the ASEAN Pharmaceutical Industry Club, an organisation which it had helped to form under the ASEAN Chamber of Commerce and Industry.
Chemical Industries Council of Malaysia (CICM):
MOPI is an honorary member of CICM Executive Committee.
International Medical University, Malaysia (IMU)
MOPI is a member of the Board of Studies - Bachelor of Pharmacy (Hons) of the lMU.
Parenteral Drug Association, USA
Member of Parenteral Drug Association, USA, an international association for pharmaceutical science and technology.
Dialogues with Minister of Health and National Pharmaceutical Control Bureau:
MOPI also holds regular dialogues with the Health Minister and the National Pharmaceutical Control Bureau to resolves issues affecting the industry.
Dialogues with Minister of International Trade & Industry:
Since 1984, MOPI has acted as representative for the Malaysian pharmaceutical industry in the annual dialogues with the Ministry of International Trade and Industry.
Dialogues with Minister of Domestic Trade & Consumer Affairs:
MOPI participates in the annual dialogue representing the industry on matters pertaining to intellectual property and consumer protection.
For more details:
Malaysian Organisation of Pharmaceutical Industries
(Reg No: 2045/81)
1st Floor, Wisma Yan, No 17 & 19, Jalan Selangor
46050 Petaling Jaya, Malaysia
Tel: 603-7957 3070/1004
Fax: 603-79560018
Website: www.mopi.org.my
Email: mopi@tm.net.my
